Tissue remodelling in breast cancer: Human mast cell tryptase as an initiator of myofibroblast differentiation

Histopathology

Volumn 58, Issue 7, 2011, Pages 1096-1106

  Mangia, Anita ^a   Malfettone, Andrea ^a   Rossi, Roberta ^b   Paradiso, Angelo ^a   Ranieri, Girolamo ^c   Simone, Giovanni ^a   Resta, Leonardo ^b  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c National Cancer Research Centre 'Giovanni Paolo II'   (Italy)

Author keywords

SMA positive myofibroblasts; Breast cancer; Toluidine blue; Tryptase positive mast cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; TOLONIUM CHLORIDE; TRYPTASE;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BREAST CANCER; CANCER INVASION; CELL DENSITY; CELL DIFFERENTIATION; CELL JUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEGRANULATION; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAST CELL; MITOCHONDRION; MYOFIBROBLAST; MYOFILAMENT; PRIORITY JOURNAL; STROMA CELL; TUMOR MICROENVIRONMENT; ULTRASTRUCTURE;

ANTIGENS, CD34; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; FIBROBLASTS; HUMANS; MAST CELLS; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; TRYPTASES;

EID: 79959751459     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03842.x     Document Type: Article

References (37)

1. Tarin D, Croft CB. Ultrastructural features of wound healing in mouse skin. J. Anat. 1969; 105; 189-190.
2. Rønnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 1996; 76; 69-125.
3. Sappino AP, Skalli O, Jackson B, Schürch W, Gabbiani G. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer 1988; 41; 707-712.
4. Nakayama H, Enzan H, Miyazaki E, Kuroda N, Naruse K, Hiroi M. Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma. J. Clin. Pathol. 2000; 53; 626-629.
5. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc. Natl Acad. Sci. USA 1993; 90; 999-1003.
6. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 2003; 200; 500-503.
7. Eyden B, Banerjee SS, Shenjere P, Fisher C. The myofibroblast and its tumours. J. Clin. Pathol. 2009; 62; 236-249.
8. Schürch W, Seemayer TA, Hinz B et al. Myofibroblast. In Mills SE ed. Histology for pathologists, 3rd edn. Philadelphia, PA: Lippincott, Williams & Wilkins, 2007; 123-164.
9. Rønnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J. Clin. Invest. 1995; 95; 859-873.
10. Zeisberg EM, Tarnavski O, Zeisberg M et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007; 13; 952-961.
11. Direkze NC, Hodivala-Dilke K, Jeffery R et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 2004; 64; 8492-8495.
12. Coussens LM, Raymond WW, Bergers G et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999; 13; 1382-1397.
13. Frungieri MB, Weidinger S, Meineke V, Köhn FM, Mayerhofer A. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma: possible relevance to human fibrotic disorders. Proc. Natl Acad. Sci. USA 2002; 99; 15072-15077.
14. Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 1991; 88; 493-499.
15. Hartmann T, Ruoss SJ, Raymond WW, Seuwen K, Caughey GH. Human tryptase as a potent, cell-specific mitogen: role of signaling pathways in synergistic responses. Am. J. Physiol. 1992; 262; L528-L534.
16. Abe M, Kurosawa M, Ishikawa O, Miyachi Y, Kido H. Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production. Clin. Exp. Allergy 1998; 28; 1509-1517.
17. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J. Clin. Invest. 1997; 99; 1313-1321.
18. Gruber BL, Kew RR, Jelaska A et al. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J. Immunol. 1997; 158; 2310-2317.
19. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 2002; 41; 151-153.
20. Mangia A, Chiriatti A, Tommasi S et al. BRCA1 expression and molecular alterations in familial breast cancer. Histol. Histopathol. 2009; 24; 69-76.
21. Mangia A, Chiriatti A, Bellizzi A et al. Biological role of NHERF1 protein expression in breast cancer. Histopathology 2009; 55; 600-608.
22. Kankkunen JP, Harvima IT, Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int. J. Cancer 1997; 72; 385-388.
23. Kashiwase Y, Morioka J, Inamura H, Yoshizawa Y, Usui R, Kurosawa M. Quantitative analysis of mast cells in benign and malignant breast lesions. Immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Int. Arch. Allergy Immunol. 2004; 134; 199-205.
24. Zudaire E, Martínez A, Garayoa M et al. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am. J. Pathol. 2006; 168; 280-291.
25. Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 2004; 25; 235-241.
26. Noël A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin. Cell Dev. Biol. 2008; 19; 52-60.
27. Hebda PA, Collins MA, Tharp MD. Mast cell and myofibroblast in wound healing. Dermatol. Clin. 1993; 11; 685-696.
28. Yamamoto T, Hartmann K, Eckes B, Krieg T. Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interaction: role of stem cell factor/c-kit. Immunology 2000; 99; 435-439.
29. Gailit J, Marchese MJ, Kew RR, Gruber BL. The differentiation and function of myofibroblasts is regulated by mast cell mediators. J. Invest. Dermatol. 2001; 117; 1113-1119.
30. Kuroda N, Toi M, Nakayama H et al. The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions. Histol. Histopathol. 2004; 19; 59-67.
31. Kuroda N, Jin YL, Hamauzu T et al. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions. Histol. Histopathol. 2005; 20; 707-712.
32. Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch. 2002; 440; 298-303.
33. Chauhan H, Abraham A, Phillips JR, Pringle JH, Walker RA, Jones JL. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J. Clin. Pathol. 2003; 56; 271-276.
34. Ramaswamy A, Moll R, Barth PJ. CD34+ fibrocytes in tubular carcinomas and radial scars of the breast. Virchows Arch. 2003; 443; 536-540.
35. Nakayama H, Enzan H, Yamamoto M et al. CD34-positive stromal cells in primary lung carcinomas. Oncol. Rep. 2003; 10; 1313-1316.
36. Nakayama H, Enzan H, Miyazaki E et al. CD34 positive stromal cells in gastric adenocarcinomas. J. Clin. Pathol. 2001; 54; 846-848.
37. Ebrahimsade S, Westhoff CC, Barth PJ. CD34+ fibrocytes are preserved in most invasive lobular carcinomas of the breast. Pathol. Res. Pract. 2007; 203; 695-698.